Brief: Torii Pharmaceutical says new drug application approval of allergen immunotherapy tablet for japanese cedar pollinosis
Sept 27 (Reuters) - Torii Pharmaceutical Co Ltd 4551.T
* Says the Japanese Ministry of Health, Labour and Welfare
has approved the new drug application of "CEDARCURE Japanese
Cedar Pollen Sublingual Tablets", an allergen immunotherapy
tablet for Japanese cedar pollinosis
Source text in Japanese:https://goo.gl/UW6Qqu
Further company coverage: 4551.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +8601082555111;
Reuters Messaging: Pingping.Li1@thomsonreuters.com@reuters.net))
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)